JSLL
NSEJeena Sikho Lifecare Limited (SMALL CAP)
Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹593.00
1.40 (0.24%)
High VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹7.37K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
33.2
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹492+20.5%
52W High₹849.5-30.2%
Current Price
₹593.00
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹474.40
Upper Circuit₹711.60
Reference Price
₹593.00
Investment Checklist
Double Top on 1W (BREAKOUT CONFIRMED) — target ₹550.0
Triple Top on 1D (BREAKOUT CONFIRMED) — target ₹590.5
Volume divergence: Bearish (price up, volume down)
SuperTrend(10,3): Price above SuperTrend (Industry Standard (Swing/Medium-Term))
SuperTrend(7,3): Price above SuperTrend (Responsive Setting (Day Trading/Short-Term))
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Confidence
44%
Trend
NEUTRAL
NEUTRAL
Mixed MA signals — sideways/transition | Bearish MA stack (20<50<200)
EMA20
587.76
EMA50
610.1
EMA200
666.55
Price Action
MIXED
NEUTRAL
Higher Highs4
Higher Lows4
Lower Highs5
Lower Lows5
Support & Resistance Levels
Resistance (Above)
₹610.10
₹634.45
₹658.12
₹679.50
₹696.00
Support (Below)
₹581.20
₹570.60
₹545.05
₹534.40
₹492.00
Volume Analysis
TrendDECREASING
Change-60.00%
Unusual VolumeNo
Divergence Detected
Bearish (price up, volume down)
Stop Loss Levels
Fixed Risk
1% Risk₹587.07
3% Risk₹575.21
5% Risk₹563.35
7% Risk (Custom)
₹551.49Technical Levels
1x ATR (Volatility)₹561.53
2x ATR (Swing)₹530.06
3x ATR (Trend)₹498.59
Immediate Support₹581.20
Moving Averages
EMA 9 (Short-term)₹581.29
EMA 20 (Medium-term)₹587.76
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹139.3 Cr | ₹174.3 Cr | ₹189.8 Cr | ₹221.7 Cr |
| Net Profit | ₹36.1 Cr | ₹51.3 Cr | ₹58.8 Cr | ₹66.7 Cr |
| EPS | — | ₹4.13 | ₹4.73 | ₹5.36 |
| Operating Profit | ₹41.3 Cr | ₹79.8 Cr | ₹93.5 Cr | ₹103.3 Cr |
ROE
33.23%
ROCE
43.19%
Debt/Equity
0.04
Current Ratio
2.91
OPM
46.59%
NPM
30.07%
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.4 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.5 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 23.0 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.4 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.3 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.6 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 26.1 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 91.5 | ₹83.02K Cr mid Cap | |
| Jeena Sikho Lifecare Limited | ₹593.00 | +0.24% | 33.2 | ₹7.37K Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 22 Sept 2025 | Dividend - Re 1.10 Per Share | DIVIDEND |
| 20 Aug 2024 | ANNUAL GENERAL MEETING/DIVIDEND - RS 4.18 PER SHARE | AGM |
| 02 Nov 2023 | BONUS 4:5 | BONUS |
| 21 Sept 2022 | ANNUAL GENERAL MEETING | AGM |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for JSLL
View AllNEWS
neutral
Business Standard - Markets 38d ago
AksharChem (India) Ltd leads gainers in 'B' group
Jeena Sikho Lifecare Ltd, JHS Svendgaard Retail Ventures Ltd, Emkay Global Financial Services Ltd and John Cockerill India Ltd are among the other gainers in the BSE's 'B' group today, 03 June 2026.
AKSHARCHEMBSECOCKERILLEMKAYGLOBALJHSJMFINANCILJSLLRETAILSDREAMSV2RETAILCapital GoodsChemicals
positive
Business Standard - Markets 38d ago
Choice reiterates 'Buy' on Jeena Sikho, sees 44% upside; stock rises 20%
Analysts Deepika Murarka and Stuti Bagadia expect JSLL to deliver revenue, Ebitda and PAT CAGR of 33.6 per cent, 34.9 per cent and 41.6 per cent, respectively, over FY26-FY29E
CHOICEINJSLLFinancial ServicesHealthcare
NEWS
neutral
Business Standard - Markets 38d ago
Jeena Sikho Lifecare Ltd leads gainers in 'B' group
Thacker & Company Ltd, HLE Glascoat Ltd, SKM Egg Products Export (India) Ltd and HCL Infosystems Ltd are among the other gainers in the BSE's 'B' group today, 02 June 2026.
BSEHCL-INSYSHCLTECHHLEGLASJSLLSKMEGGPRODTHACKERCapital GoodsFast Moving Consumer Goods